The safety and effectiveness of sleep apnea equipment will be examined,evaluated, and determined with the help of a research study conducted by Winston-Salem Company.

Winston-Salem announced that  it has received approval to begin a clinical study to evaluate the  safety and effectiveness of the Apnex hypoglossal Nerve Stimulation (HGNS) System. The device is used to treat obstructive sleep apnea (OSA).

PMG will be one of the first medical centers in the country to participate in this study. “Many people who suffer from OSA are unable to tolerate existing therapies such as continuous positive airway pressure (CPAP). The HGNS System provides a new approach to the treatment of OSA. This study will help us  further understand what role this device could have in treating the millions of people who suffer from OSA,” said the study’s co-principal investigator.

 “We are excited to be part of this important study”, explained Dr. Jason Thomason, from  Salem Chest Specialists and the lead trial investigator at PMG Research.

The Apnex Clinical Study is now enrolling patients. People who are interested in learning if they might qualify for the study can call 1-888-975-3370 begin_of_the_skype_highlighting            1-888-975-3370     end_of_the_skype_highlighting or click here.

Related Posts with Thumbnails

Tagged with:

Filed under: Clinical ResearchClinical TrialsCPAPCPAP TherapyObstructive Sleep ApneaSleep ApneaSleep Apnea DevicesSleep Apnea EquipmentsSleep Apnea EventsSleep Apnea NewsSleep Apnea ResearchSleep Apnea StudySleep Apnea TreatmentSleep Center

Like this post? Subscribe to my RSS feed and get loads more!